Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.23.1
Stock-Based Compensation (Tables)
6 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Summary of Stock Option Activity

The following table summarizes stock option activity for the fiscal year ended September 30, 2022 and the six months ended March 31, 2023:

 

 

 

Number of
Shares

 

 

Weighted
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual Life

 

 

Intrinsic
Value

 

Outstanding at September 30, 2021

 

 

87,500

 

 

$

18.81

 

 

 

1.78

 

 

$

1,626

 

Outstanding at September 30, 2022

 

 

87,500

 

 

$

18.81

 

 

 

0.78

 

 

$

771

 

Exercisable at September 30, 2022

 

 

87,500

 

 

$

18.81

 

 

 

0.78

 

 

$

771

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at September 30, 2022

 

 

87,500

 

 

$

18.81

 

 

 

0.78

 

 

$

771

 

Outstanding at March 31, 2023

 

 

87,500

 

 

$

18.81

 

 

 

0.85

 

 

$

1,160

 

Exercisable at March 31, 2023

 

 

87,500

 

 

$

18.81

 

 

 

0.85

 

 

$

1,160

 

Schedule of weighted average fair value ("WAFV") of unvested restricted stock awards

The following table presents the number and weighted average fair value ("WAFV") of unvested restricted stock awards:

 

 

 

Series A Restricted Stock Awards

 

 

WAFV

 

Outstanding at September 30, 2022

 

 

 

 

$

 

Granted

 

 

27,307

 

 

$

36.62

 

Vested

 

 

 

 

$

 

Canceled

 

 

 

 

$

 

Non-vested at December 31, 2022

 

 

27,307

 

 

$

36.62